1. |
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation, 2023, 147(8): e93-e621.
|
2. |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告 2020 概要. 中国循环杂志, 2021, 36(6): 521-545.
|
3. |
Ahmadi Z, Hassanshahi G, Khorramdelazad H, et al. An overlook to the characteristics and roles played by eotaxin network in the pathophysiology of food allergies: allergic asthma and atopic dermatitis. Inflammation, 2016, 39(3): 1253-1267.
|
4. |
Noroozi Karimabad M, Khanamani Falahati-Pour S, Hassanshahi G. Significant role(s) of CXCL12 and the SDF-1 3’A genetic variant in the pathogenesis of multiple sclerosis. Neuroimmunomodulation, 2016, 23(4): 197-208.
|
5. |
Morein D, Erlichman N, Ben-Baruch A. Beyond cell motility: the expanding roles of chemokines and their receptors in malignancy. Front Immunol, 2020, 11: 952.
|
6. |
Mousavi A. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy. Immunol Lett, 2020, 217: 91-115.
|
7. |
Wang X, Wang H, Wei X, et al. Effect of CXCR4 silencing with shRNA on MAPK signaling in ovarian cancer. Oncol Lett, 2018, 15(6): 10026-10030.
|
8. |
Koch C, Engele J. Functions of the CXCL12 receptor ACKR3/CXCR7—what has been perceived and what has been overlooked. Mol Pharmacol, 2020, 98(5): 577-585.
|
9. |
Harrison MR, Bussmann J, Huang Y, et al. Chemokine-guided angiogenesis directs coronary vasculature formation in zebrafish. Dev Cell, 2015, 33(4): 442-454.
|
10. |
Cavallero S, Shen H, Yi C, et al. CXCL12 signaling is essential for maturation of the ventricular coronary endothelial plexus and establishment of functional coronary circulation. Dev Cell, 2015, 33(4): 469-477.
|
11. |
Ivins S, Chappell J, Vernay B, et al. The CXCL12/CXCR4 axis plays a critical role in coronary artery development. Dev Cell, 2015, 33(4): 455-468.
|
12. |
Chang AH, Raftrey BC, D’Amato G, et al. DACH1 stimulates shear stress-guided endothelial cell migration and coronary artery growth through the CXCL12-CXCR4 signaling axis. Genes Dev, 2017, 31(13): 1308-1324.
|
13. |
Ceholski DK, Turnbull IC, Pothula V, et al. CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response. Stem Cell Res, 2017, 23: 77-86.
|
14. |
Koenen J, Bachelerie F, Balabanian K, et al. Atypical chemokine receptor 3 (ACKR3): a comprehensive overview of its expression and potential roles in the immune system. Mol Pharmacol, 2019, 96(6): 809-818.
|
15. |
Lau S, Feitzinger A, Venkiteswaran G, et al. A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration. Nat Cell Biol, 2020, 22(3): 266-273.
|
16. |
Doijen J, Van Loy T, De Haes W, et al. Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements. PLoS One, 2017, 12(9): e0185354.
|
17. |
Yu L, Pham Q, Yu LL, et al. Modulation of CXC-motif chemokine receptor 7, but not 4, expression is related to migration of the human prostate cancer cell LNCaP: regulation by androgen and inflammatory stimuli. Inflamm Res, 2020, 69(2): 167-178.
|
18. |
Del Molino Del Barrio I, Wilkins GC, Meeson A, et al. Breast cancer: an examination of the potential of ACKR3 to modify the response of CXCR4 to CXCL12. Int J Mol Sci, 2018, 19(11): 3592.
|
19. |
Ghadge SK, Messner M, Seiringer H, et al. Smooth muscle specific ablation of CXCL12 in mice downregulates CXCR7 associated with defective coronary arteries and cardiac hypertrophy. Int J Mol Sci, 2021, 22(11): 5908.
|
20. |
Li L, Du Z, Rong B, et al. Foam cells promote atherosclerosis progression by releasing CXCL12. Biosci Rep, 2020, 40(1): BSR20193267.
|
21. |
Döring Y, van der Vorst EPC, Duchene J, et al. CXCL12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease. Circulation, 2019, 139(10): 1338-1340.
|
22. |
Döring Y, Noels H, van der Vorst EPC, et al. Vascular CXCR4 limits atherosclerosis by maintaining arterial integrity: evidence from mouse and human studies. Circulation, 2017, 136(4): 388-403.
|
23. |
Mause SF, Ritzel E, Deck A, et al. Engagement of the CXCL12-CXCR4 axis in the interaction of endothelial progenitor cell and smooth muscle cell to promote phenotype control and guard vascular homeostasis. Int J Mol Sci, 2022, 23(2): 867.
|
24. |
Gao JH, He LH, Yu XH, et al. CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway. J Lipid Res, 2019, 60(12): 2020-2033.
|
25. |
Li X, Zhu M, Penfold ME, et al. Activation of CXCR7 limits atherosclerosis and improves hyperlipidemia by increasing cholesterol uptake in adipose tissue. Circulation, 2014, 129(11): 1244-1253.
|
26. |
Qiu L, Zhang M, Zhang S, et al. Activation of ACKR3 promotes endothelial repair and reduces the carotid atherosclerotic lesions through inhibition of pyroptosis signaling pathways. Aging Cell, 2020, 19: e13205.
|
27. |
Sjaarda J, Gerstein H, Chong M, et al. Blood CSF1 and CXCL12 as causal mediators of coronary artery disease. J Am Coll Cardiol, 2018, 72(3): 300-310.
|
28. |
Tavakolian Ferdousie V, Mohammadi M, Hassanshahi G, et al. Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion. Int J Cardiol, 2017, 233: 23-28.
|
29. |
Peiró ÓM, Farré N, Cediel G, et al. Stromal cell derived factor-1 and long-term prognosis in acute coronary syndrome. Biomark Med, 2019, 13(14): 1187-1198.
|
30. |
Oprescu N, Micheu MM, Scafa-Udriste A, et al. Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease. Ann Med, 2021, 53(1): 1041-1047.
|
31. |
Das S, Goldstone AB, Wang H, et al. A Unique collateral artery development program promotes neonatal heart regeneration. Cell, 2019, 176(5): 1128-1142.
|
32. |
Marín-Juez R, El-Sammak H, Helker CSM, et al. Coronary revascularization during heart regeneration is regulated by epicardial and endocardial cues and forms a scaffold for cardiomyocyte repopulation. Dev Cell, 2019, 51(4): 503-515.
|
33. |
Mayorga ME, Kiedrowski M, McCallinhart P, et al. Role of SDF-1: CXCR4 in impaired post-myocardial infarction cardiac repair in diabetes. Stem Cells Transl Med, 2018, 7(1): 115-124.
|
34. |
Gong XH, Liu H, Wang SJ, et al. Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. J Cell Physiol, 2019, 234(8): 13878-13893.
|
35. |
Jarrah AA, Schwarskopf M, Wang ER, et al. SDF-1 induces TNF-mediated apoptosis in cardiac myocytes. Apoptosis, 2018, 23(1): 79-91.
|
36. |
Bromage DI, Davidson SM, Yellon DM. Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther, 2014, 143(3): 305-315.
|
37. |
Bromage DI, Taferner S, He Z, et al. Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury. J Mol Cell Cardiol, 2019, 128: 187-197.
|
38. |
Wang Y, Dembowsky K, Chevalier E, et al. C-X-C motif chemokine receptor 4 blockade promotes tissue repair after myocardial infarction by enhancing regulatory T cell mobilization and immune-regulatory function. Circulation, 2019, 139(15): 1798-1812.
|
39. |
Ziff OJ, Bromage DI, Yellon DM, et al. Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy. Cardiovasc Res, 2018, 114(3): 358-367.
|
40. |
Hao H, Hu S, Chen H, et al. Loss of endothelial CXCR7 impairs vascular homeostasis and cardiac remodeling after myocardial infarction: implications for cardiovascular drug discovery. Circulation, 2017, 135(13): 1253-1264.
|
41. |
Ishizuka M, Harada M, Toko H, et al. CXCL7 in cardiomyocytes prevents cardiac dysfunction after myocardial infarction. Eur Heart J, 2020, 41(Suppl 2): 3647.
|
42. |
Ishizuka M, Harada M, Nomura S, et al. CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor. Sci Rep, 2021, 11(1): 3426.
|
43. |
Zhang S, Yue J, Ge Z, et al. Activation of CXCR7 alleviates cardiac insufficiency after myocardial infarction by promoting angiogenesis and reducing apoptosis. Biomed Pharmacother, 2020, 127: 110168.
|
44. |
Zhang J, Zhang Y, Xin S, et al. CXCR7 suppression modulates macrophage phenotype and function to ameliorate post-myocardial infarction injury. Inflamm Res, 2020, 69(5): 523-532.
|
45. |
Rath D, Chatterjee M, Meyer L, et al. Relative survival potential of platelets is associated with platelet CXCR4/CXCR7 surface exposure and functional recovery following STEMI. Atherosclerosis, 2018, 278: 269-277.
|
46. |
Li X, Weng X, Shi H, et al. Acetaldehyde dehydrogenase 2 deficiency exacerbates cardiac fibrosis by promoting mobilization and homing of bone marrow fibroblast progenitor cells. J Mol Cell Cardiol, 2019, 137: 107-118.
|
47. |
Jackson EK, Zhang Y, Gillespie DD, et al. SDF-1α (stromal cell-derived factor 1α) induces cardiac fibroblasts, renal microvascular smooth muscle cells, and glomerular mesangial cells to proliferate, cause hypertrophy, and produce collagen. J Am Heart Assoc, 2017, 6(11): e007253.
|
48. |
Projahn D, Simsekyilmaz S, Singh S, et al. Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction. J Cell Mol Med, 2014, 18(5): 790-800.
|
49. |
Puca AA, Carrizzo A, Spinelli C, et al. Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism. Eur Heart J, 2020, 41(26): 2487-2497.
|
50. |
Upadhye A, Srikakulapu P, Gonen A, et al. Diversification and CXCR4-dependent establishment of the bone marrow B-1a cell pool governs atheroprotective IgM production linked to human coronary atherosclerosis. Circ Res, 2019, 125(10): e55-e70.
|
51. |
Huang FY, Xia TL, Li JL, et al. The bifunctional SDF-1-AnxA5 fusion protein protects cardiac function after myocardial infarction. J Cell Mol Med, 2019, 23(11): 7673-7684.
|
52. |
Wang H, Wisneski A, Paulsen MJ, et al. Bioengineered analog of stromal cell-derived factor 1α preserves the biaxial mechanical properties of native myocardium after infarction. J Mech Behav Biomed Mater, 2019, 96: 165-171.
|
53. |
Jeong HS, Park CY, Kim JH, et al. Cardioprotective effects of genetically engineered cardiac stem cells by spheroid formation on ischemic cardiomyocytes. Mol Med, 2020, 26(1): 15.
|
54. |
Hess A, Derlin T, Koenig T, et al. Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. Eur Heart J, 2020, 41(37): 3564-3575.
|